bims-medica Biomed News
on Metabolism and diet in cancer
Issue of 2026–11–15
seventeen papers selected by
Brett Chrest, Wake Forest University



  1. bioRxiv. 2026 Oct 20. pii: 2026.10.18.759986. [Epub ahead of print]
      Metabolic state is tightly linked to cell fate, and expression of the mitochondrial pyruvate carrier (MPC), which imports pyruvate into mitochondria, is a robust marker of it. The transcriptional regulators that set metabolic state, however, remain poorly defined. In the liver, β-catenin is one of the determinants of metabolic zonation, and activating CTNNB1 mutations are frequent in hepatocellular carcinoma. Here we show that β-catenin regulates metabolic state in liver cancer cells. An unbiased CRISPR screen that uses endogenous MPC1 transcript abundance as the marker identifies CTNNB1 . Activating β-catenin pharmacologically or genetically reduces MPC1 and MPC2 transcript and protein levels, and MPC expression is also low in β-catenin-driven liver tumors in vivo. Beyond the MPC, β-catenin activation impairs assembly of respiratory Complexes III and IV, reduces mitochondrial DNA content and respiratory capacity, elongates mitochondrial networks and remodels the lipidome. Stable isotope tracing shows reduced entry of glucose- and lactate-derived carbon into the TCA cycle alongside increased oxidation of palmitate and oleate. These findings identify β-catenin as a regulator of metabolic state that drives a fuel switch from carbohydrate to fatty acid oxidation in liver cancer cells.
    DOI:  https://doi.org/10.64898/2026.10.18.759986
  2. Cells. 2026 Nov 06. pii: 2026. [Epub ahead of print]15(21):
      In humans, six common non-synonymous exonic single-nucleotide polymorphisms in ALDH1L1 lead to ten enzyme haplotypes. Since ALDH1L1 is a metabolic regulator and a candidate tumor suppressor, we studied how haplotype variants affect metabotypes, proliferation and motility. Using lentiviral delivery to A549 and PC3 cells, we have generated two cell panels, with each cell line in the panel carrying one of ten ALDH1L1 haplotype variants. Untargeted metabolomics revealed strong differences in metabotypes between cells carrying ALDH1L1 variants. Certain ALDH1L1 variants had decreased ability to regulate one-carbon metabolism and downstream pathways, including amino acid and glutathione metabolism, nucleotide biosynthesis, and the TCA cycle. The direct comparison of A549 and PC3 cells using an untargeted metabolomic dataset also showed that the two cell lines have vastly different metabotypes. In agreement with this finding, the analysis of A549 and PC3 ALDH1L1 haplotype panels suggested that the ALDH1L1-linked metabolic regulation is strongly influenced by specific cellular metabotypes and genetic background. ALDH1L1 variants also exhibited reduced inhibition of cellular proliferation and motility compared to the most common haplotype, which supports further investigation of their potential relevance to individual risk of metabolic disorders.
    Keywords:  ALDH1L1; cancer metabolism; exonic SNPs; tumor suppression; untargeted metabolomics
    DOI:  https://doi.org/10.3390/cells15212026
  3. Int J Mol Sci. 2026 Oct 26. pii: 9570. [Epub ahead of print]27(21):
      Prolonged fasting with no caloric intake induces a metabolic shift characterized by increased fat oxidation and ketone production. However, the magnitude of circulating ketone responses and their dependence on fasting duration have not been quantitatively synthesized. This systematic review and meta-analysis evaluated the effects of water-only fasting and other prolonged fasting protocols involving complete caloric abstinence on circulating ketone biomarkers and examined whether fasting duration moderates these responses. PubMed, Web of Science, and Scopus were searched for human studies published between 2000 and 2025. Eligible studies reported pre-post measurements of β-hydroxybutyrate (BHB), acetoacetate, or total plasma ketones following water-only or other non-caloric fasting protocols. Random-effects meta-analyses were performed using Hedges' g. Duration effects were assessed through subgroup analyses (≤3 days vs. >3 days) and random-effects meta-regression with study-level cluster-robust standard errors. Thirty studies providing 44 effect sizes were included. Fasting significantly increased BHB (g = 2.794), total plasma ketones (g = 3.260), and acetoacetate (g = 1.731). Greater elevations in BHB and total plasma ketones were observed with fasting durations exceeding three days. Meta-regression indicated significant positive associations between fasting duration and responses for BHB and total plasma ketones, whereas no significant association was detected for acetoacetate. Despite substantial heterogeneity for BHB and total plasma ketones, sensitivity analyses supported the robustness of the pooled effects. Small-study effects were detected for BHB, whereas funnel-plot asymmetry for total plasma ketones was considered exploratory because of the limited number of studies. Water-only fasting and other prolonged fasting protocols involving complete caloric abstinence are associated with marked increases in circulating ketone bodies, with a clear duration-dependent pattern observed particularly for BHB and total plasma ketones.
    Keywords:  acetoacetate; duration-dependent effects; ketone bodies; meta-analysis; meta-regression; water-only fasting; β-hydroxybutyrate
    DOI:  https://doi.org/10.3390/ijms27219570
  4. Nat Metab. 2026 Nov 13.
      Brown adipose tissue (BAT) is a cold-activated organ that uncouples mitochondrial respiration from ATP synthesis to produce heat. Activated BAT can consume an extreme amount of glucose, per gram of tissue, in both mice and humans. However, the contexts, mechanisms and necessity for BAT glucose utilization remain surprisingly undefined in vivo. Here we show that while BAT thermogenesis is maintained across diverse dietary contexts, its glucose utilization is particularly responsive to diet. Importantly, we find cold-induced BAT glucose uptake and thermogenesis to be independent of the previously proposed critical transporter, GLUT1. Instead, inducible GLUT4 loss eliminates cold-induced glucose uptake and compromises BAT thermogenesis only when dietary lipids are low during cold stress. We furthermore illustrate the unexpected capacity for brown adipocytes to sustain ATP levels without glycolysis, even during substantial mitochondrial uncoupling, when alternative nutrients are abundant. Collectively, our work demonstrates that BAT sustains thermogenesis through marked metabolic flexibility across nutrient contexts.
    DOI:  https://doi.org/10.1038/s42255-026-01652-3
  5. Res Sq. 2026 Oct 22. pii: rs.3.rs-10883518. [Epub ahead of print]
      Glucose-6-phosphate (G6P) is a key intermediate in multiple energetic and anabolic pathways, and quantifying its dynamics is essential for understanding cellular physiology. We have previously developed a syndicate of intensity-based, genetically encoded sensors based on the insertion of circularly permuted GFP into a Venus-flytrap-like analyte-binding protein. Here we use the same approach to develop an intensity-based G6P Sensing Fluorescent Reporter (iG6PSnFR). We present two variants: a G6P-activated sensor that increases fluorescence and a G6P-inactivated sensor that decreases fluorescence. We validate performance across progressively more complex preparations, including purified protein in vitro, immortalized and primary neuronal cultures, isolated pancreatic islets, in an intravital liver model, and finally in vivo in C. elegans neurons. In each context, iG6PSnFR reports G6P changes consistent with expected responses to physiological perturbations.
    DOI:  https://doi.org/10.21203/rs.3.rs-10883518/v1
  6. Cancer Cell Int. 2026 Aug 17. pii: 360. [Epub ahead of print]26(1):
       BACKGROUND: Metabolic reprogramming is a hallmark of breast cancer (BrCa), with alterations in glycolysis, glutamine metabolism, and the urea cycle contributing to tumour progression. Dichloroacetate (DCA), a pyruvate dehydrogenase kinase (PDK) inhibitor, shifts metabolism toward oxidative phosphorylation and has been proposed as a therapeutic agent. While isotope tracing is well-established, natural isotope abundance (δ¹³C, δ¹⁵N) is emerging as a biomarker of metabolic alterations in cancer.
    METHODS: We investigated the relationship between isotope composition and metabolism in BrCa using two BALB/c mouse mammary tumour models (V14 and 4T1) and assessed the effects of DCA treatment using metabolomics, lipidomics and isotopomics.
    RESULTS: V14 and 4T1 tumours exhibited isotopic patterns similar to human tumours, with δ¹³C enrichment and δ¹⁵N depletion relative to non-cancerous mammary tissue. V14 tumours were more δ¹⁵N-depleted than 4T1, reflecting differences in nitrogen metabolism. Multivariate analysis integrating isotopic, metabolomic, and lipidomic data revealed isotopic features as key discriminators between tumours and normal tissues. Compared to V14, 4T1 tumours were enriched in TCA intermediates, sphingolipids, and amino acids, whereas V14 tumours showed elevated glutaminolytic and nitrogenous metabolites. DCA treatment differentially affected tumour growth, with V14 tumours more sensitive than 4T1. DCA altered nitrogen metabolism, increasing the arginine-to-ornithine ratio, and modulating δ¹⁵N values in a tumour-specific manner increasing V14 and decreasing 4T1 δ¹⁵N values. DCA had little effect on δ¹³C. δ¹³C values were primarily determined by the balance between lipid and TCA cycle metabolites, rather than glycolytic flux. δ¹⁵N variation was linked to nitrogen metabolism, including urea cycle intermediates and sphingolipid composition, with a potential role for choline-related fractionation in δ¹⁵N depletion. Altered gene expression of Hacd2 and Acot12 in V14 tumours after DCA treatment was reflected in shorter fatty acid tails in phosphatidyl cholines, supporting the lipidomics data.
    CONCLUSIONS: These findings support the hypothesis that cancer-associated metabolic reprogramming influences natural isotope abundance. Correlations between isotope shifts and metabolic signatures highlight the potential of lipid-derived δ¹⁵N as a biomarker of tumour metabolic state, with implications for noninvasive metabolic profiling in BrCa.
    Keywords:  Breast cancer; Dichloroacetate; Lipidomics; Mammary tumour; Metabolomics; Natural isotope abundance
    DOI:  https://doi.org/10.1186/s12935-026-04446-5
  7. Proc Natl Acad Sci U S A. 2026 Nov 17. 123(46): e2613433123
      The electron transport chain is a signaling hub for hydrogen sulfide (H2S) that serves both as a respiratory substrate and an inhibitor. While acute sulfide toxicity is well characterized, cellular adaptations to chronic H2S, particularly microbially-derived sulfide exposure in colon, is poorly understood. We report that chronic, low-level H2S exposure (4 to 20 µM) drives robust carbon sequestration in lipid droplets (LD) across several human cell lines, driven by a coordinated remodeling of redox and nucleotide metabolism. Specifically, H2S-induced reductive shifts in nicotinamide adenine dinucleotide (NAD) and coenzyme Q (CoQ) pools are accompanied by glycerol-3-phosphate accumulation and cytidine triphosphate (CTP) depletion. Lipidomic analysis reveals increased neutral lipid synthesis and triacylglyceride accumulation concomitant with decreased CTP-dependent synthesis of membrane phospholipids. Mitochondrial expression of a water-generating NADH oxidase attenuates LD accumulation and spatially confines the origin of H2S-induced reductive stress signaling to this compartment. Interestingly, LD abundance increases even after H2S withdrawal, continuing over 48 h, during which time the reductively-shifted NAD and CoQ pools slowly reoxidize. Inhibition of fatty acid synthesis during sulfide exposure impairs cellular recovery of respiration. These findings establish an active role for LDs in stress response and reveal that lipid biogenesis is a strategy for countering H2S-induced redox imbalance. The sulfide-LD-redox axis uncovered in this study has implications for understanding how gut-derived H2S, shaped by diet and microbiome, can influence metabolic health.
    Keywords:  lipid droplet; metabolism; redox
    DOI:  https://doi.org/10.1073/pnas.2613433123
  8. J Biol Chem. 2026 Nov 12. pii: S0021-9258(26)02614-1. [Epub ahead of print] 113742
      Differentiation of skeletal muscle is associated with increased mitochondrial biogenesis and reliance on oxidative phosphorylation (OXPHOS). The terminal enzyme complex in the electron transport chain, cytochrome c oxidase (COX), requires copper for its assembly and activity, and copper delivery to mitochondria is essential for OXPHOS. However, when mitochondrial copper becomes essential during skeletal myoblast differentiation is not known. Here, we show that inducing genetic deficiency of the mitochondrial copper and phosphate carrier SLC25A3 prior to myoblast differentiation leads to the formation of smaller myotubes, but SLC25A3 deficiency induced in mature myotubes leads to cell death and detachment. Both phenotypes are recapitulated upon genetic knockdown of COX17, a key chaperone for COX copper cofactor assembly, and by chemical inhibition of COX. Importantly, myotube death caused by SLC25A3 deficiency is reversed by copper supplementation. Expression of an SLC25A3 isoform A variant that is equivalent to a variant in isoform B that exclusively transports copper also rescues myotube viability. Taken together these data support a model wherein SLC25A3 is critical for survival in mature myotubes, likely due to its role in providing copper to COX.
    Keywords:  copper; copper transport; cytochrome c oxidase (Complex IV); myogenesis; skeletal muscle
    DOI:  https://doi.org/10.1016/j.jbc.2026.113742
  9. Metabol Open. 2026 Dec;32 100517
      Disruptions in ketone metabolism can markedly impair energy homeostasis and clinical outcomes in individuals with certain inborn errors of metabolism (IEMs), making ketone monitoring an important component of disease management. Evidence for ketone monitoring has largely emerged from diabetes care, where it reduces the risk of diabetic ketoacidosis (DKA), hospitalizations, and healthcare costs. However, conventional ketone self-monitoring methods are limited by impracticality and lack of longitudinal data. Continuous ketone monitoring (CKM), which measures subcutaneous beta-hydroxybutyrate (BHB), overcomes these limitations by enabling real-time assessment of ketone dynamics. In this narrative review, we discuss emerging CKM technologies for the first time and outline their potential clinical utility in IEMs. However, direct clinical evidence supporting the use of CKM in IEMs is currently lacking, and further studies are needed to validate these proposed applications. In theory, CKM could improve metabolic control, seizure management, and prevent complications in disorders of ketolysis and in individuals with IEMs on ketogenic dietary therapies; help in early detection of catabolic states and metabolic decompensation; and enhance surveillance for DKA in IEM-associated insulin-deficient diabetes. Given the predictable metabolic vulnerability of patients with IEMs and the need for timely intervention, these disorders may represent a clinically meaningful early application of CKM beyond diabetes.
    Keywords:  Beta-hydroxybutyrate; CKM; Continuous ketone monitoring; Inborn errors of metabolism; Ketogenic diet
    DOI:  https://doi.org/10.1016/j.metop.2026.100517
  10. Elife. 2026 Nov 11. pii: RP109761. [Epub ahead of print]15
      Mitochondrial dysfunction and declining ATP production are common features of aging, yet whether ATP availability itself directly regulates cellular lifespan is unclear. However, the causal relationship between cellular ATP homeostasis and aging has not been established. Here, we developed a synthetic system to manipulate intracellular ATP independently of endogenous energy production by expressing a plasma membrane-targeted nucleotide transporter, NTT1, from the intracellular parasite Encephalitozoon cuniculi in Saccharomyces cerevisiae. NTT1 expression depleted intracellular ATP in the absence of extracellular ATP, whereas ATP supplementation produced robust NTT1-dependent ATP uptake, and increased intracellular ATP abundance. ATP availability strongly influenced replicative lifespan: ATP depletion shortened lifespan, whereas ATP supplementation restored and extended lifespan in NTT1-expressing cells. Unexpectedly, extracellular ATP also extended lifespan in wild-type cells that lack ATP import, revealing an NTT1-independent response to extracellular ATP. Transcriptomic analyses showed that NTT1-mediated ATP import suppresses glucose uptake, carbohydrate catabolism, mitochondrial respiration, and autophagy, whereas extracellular ATP elicits a distinct transcriptional response in wild-type cells involving metabolic, mitochondrial, and signaling pathways. Single-cell aging analyses further showed that ATP supplementation extends lifespan across distinct aging trajectories and shifts cells away from the mitochondrial dysfunction-associated aging state. Finally, experiments in cells lacking mitochondrial DNA separated these effects mechanistically: NTT1-associated lifespan phenotypes and high-ATP toxicity required functional mitochondria, whereas extracellular ATP extended lifespan in wild-type cells independently of mitochondrial respiration. Together, these findings demonstrate that ATP availability is a direct regulator of cellular aging and reveal distinct metabolic and extracellular ATP-responsive routes through which cellular energy state influences longevity.
    Keywords:  ATP; S. cerevisiae; aging; cell biology; energy metabolism; mitochondria; nucleotide transport; yeast
    DOI:  https://doi.org/10.7554/eLife.109761
  11. Nature. 2026 Nov 11.
      Somatic evolution in ageing tissues underlies many cancers1,2. However, our quantitative understanding of the rules governing this pre-cancerous evolution remains incomplete. Here we exploit a unique collection of serial blood samples3, collected annually for up to a decade and beginning as early as 15 years before diagnosis of acute myeloid leukaemia, to provide a quantitative description of pre-cancerous evolutionary dynamics. Using deep duplex sequencing and evolutionary theory, we quantify the acquisition ages and fitness effects of the key driver events in acute myeloid leukaemia development. The first driver mutations are typically acquired in the first few decades of life, when the blood remains highly polyclonal. These early slow-growing clones subsequently acquire multiple further driver mutations that confer selective advantages up to 100-fold larger than the early drivers. These faster-growing clones harbouring multiple driver mutations can cause complete somatic sweeps of the blood decades before diagnosis, a feature strongly associated with future acute myeloid leukaemia. Our data show that the clonal dynamics of blood are consistent with a set of remarkably simple evolutionary rules that strike a balance between chance and determinism.
    DOI:  https://doi.org/10.1038/s41586-026-11269-x
  12. Yale J Biol Med. 2026 Sep;99(3): 452-465
      Glioblastoma (GBM) is a lethal and treatment-resistant brain tumor characterized by altered energy metabolism and mitochondrial dysfunction. Cytochrome c oxidase subunit 4 isoform 1 (COX4-1), a nuclear-encoded component of complex IV in the electron transport chain, supports oxidative phosphorylation by facilitating electron transfer to oxygen; however, its role in carcinogenesis remains unclear. This study investigated the function of COX4-1 in GBM and its impact on mitochondrial activity and malignant behavior in vitro. COX4-1 expression in GBM cell lines was analyzed using the DepMap database and validated by quantitative real-time polymerase chain reaction. GBM cells were transfected with COX4-1 siRNA. Cell proliferation, migration, and invasion were assessed using viability, wound-healing, and transwell assays, while apoptosis and mitochondrial membrane potential were evaluated by flow cytometry. Mitochondrial function was examined through mitochondrial DNA (mtDNA) copy number, ATP levels, oxygen consumption rate, lactate dehydrogenase activity, and reactive oxygen species production, along with the expression of genes regulating mitochondrial biogenesis and dynamics. COX4-1 was upregulated in GBM cell lines (U-87MG and LN-18). Its silencing suppressed proliferation, migration, and invasion while promoting apoptosis. COX4-1 knockdown also reduced mtDNA copy number, ATP production, and oxygen consumption rate, and increased reactive oxygen species, lactate dehydrogenase activity, and membrane depolarization, thereby indicating impaired mitochondrial respiratory capacity. Additionally, COX4-1 depletion downregulated biogenesis (PGC-1α, NRF1, NRF2, TFAM) and fusion (MFN1, OPA1) regulators while upregulating the fission gene DRP1. Overall, COX4-1 depletion disrupts mitochondrial integrity and bioenergetics, leading to metabolic collapse and reduced malignancy, thereby representing a promising target for mitochondria-based therapeutic strategies in GBM.
    Keywords:  COX4-1; Glioblastoma; Invasion; Migration; Proliferation; mitochondrial function; mitochondrial metabolism
    DOI:  https://doi.org/10.59249/MWVA3688
  13. bioRxiv. 2026 Oct 21. pii: 2026.10.20.760526. [Epub ahead of print]
      Accumulation of oncometabolites promotes tumorigenesis, but it is not known if there are naturally occurring tumor suppressor metabolites whose deficiency within cancer-initiating cells causes cancer. Many leukemia patients are ascorbate deficient. Here we show that hematopoietic-specific ascorbate depletion in mice is sufficient to cause or promote leukemogenesis. Hematopoietic-specific ascorbate depletion promoted leukemogenesis by acting within leukemia initiating cells. Ascorbate depletion in myeloid leukemia expanded plasmacytoid dendritic cells, an effect mediated by the ascorbate molecular targets TET2 and TET3. Leukemia cells accumulated ascorbate as part of a tumor suppressor response to neoplastic proliferation that limited progression but depleted circulating ascorbate. Ascorbate restoration in mice with established leukemias extended survival. Hematopoietic-specific ascorbate depletion caused leukemia in collaboration with TET2 loss and was sufficient to cause leukemia with high penetrance even in the absence of other engineered mutations. These results identify ascorbate as a physiological tumor suppressor metabolite in blood cancers.
    DOI:  https://doi.org/10.64898/2026.10.20.760526
  14. Biochem Soc Trans. 2026 Nov 25. 54(11): 1623-1634
      Phospholipid remodelling is commonly used as an umbrella term for enzymatic changes in phospholipid fatty acyl chain composition after initial synthesis. This process is typically mediated by the Lands cycle, in which phospholipase-generated lysophospholipid intermediates are reacylated by lysophospholipid acyltransferases (LPLATs). However, not all lysophospholipid acylation reactions serve the same biological purpose. Some LPLAT activities remodel pre-existing phospholipid classes, tuning membrane properties by altering acyl chain composition. Others act as committed biosynthetic steps, generating defined phospholipid products whose acyl chains are integral to their identity and function. This distinction is essential for interpreting both enzyme function and lipidomics data, because individual phospholipid species may represent either molecular variants within a broader class or products with specific biological roles. In this review, I argue that grouping all lysophospholipid acylation reactions under the single label of phospholipid remodelling can obscure important biological differences. Separating remodelling from biosynthetic functions of mammalian LPLATs provides a clearer framework for understanding phospholipid metabolism, membrane organisation and mechanisms linking phospholipid metabolism to human disease.
    Keywords:  acyl chain remodelling; lipidomics; lysophospholipid acyltransferases; membrane composition; phospholipid remodelling; phospholipids
    DOI:  https://doi.org/10.1042/BST20250125
  15. bioRxiv. 2026 Oct 19. pii: 2026.10.13.758907. [Epub ahead of print]
      The Voltage-Dependent Anion Channel (VDAC) forms a unique pathway across the mitochondrial outer membrane for small ions and water-soluble metabolites, such as ATP and ADP. Despite VDAC's involvement in both normal regulation of respiration and in a wide variety of mitochondria-associated pathologies, there are, surprisingly, no known FDA-approved pharmacological agents targeting VDAC. Earlier, we have shown that VDAC can be regulated through its interactions with well-known cytosolic proteins - dimeric tubulin and α-synuclein (αSyn) - that are able to reversibly block this channel at nanomolar concentrations. We hypothesized that the architecture of a prospective VDAC inhibitor should fulfill two main requirements: possess a negatively charged disordered polypeptide C- or N-terminus as a pore blocking domain and feature a mitochondrial membrane-binding domain. Using αSyn as a template, we engineered three peptides and demonstrated that they all characteristically block VDAC reconstituted into planar lipid membranes in a controllable manner, thereby mimicking the actions of tubulin and αSyn. The VDAC blockage times induced by the synthetic peptides are comparable to αSyn-induced blockages, though the half-effect solution concentration for synthetic blockers is a hundred times higher than that of αSyn. Our work can be considered a proof-of-principle study that informs future development of mitochondria-targeting pharmacological tools.
    DOI:  https://doi.org/10.64898/2026.10.13.758907
  16. Res Sq. 2026 Oct 29. pii: rs.3.rs-11273064. [Epub ahead of print]
      Age-related cortical bone loss is driven in part by increased osteoclast activity, but the mechanisms that sustain osteoclast function during skeletal aging remain poorly defined. Here, we show that aging remodels osteoclast metabolism, increasing glycolytic ATP production and reshaping metabolites linked to early tricarboxylic acid (TCA) cycle metabolism. Metabolomic profiling identified a glycolysis-coupled TCA node marked by increased isocitrate and -ketoglutarate in aged osteoclasts. These cells also exhibited prolonged survival and reduced activation of regulated cell-death pathways; in mice, this was accompanied by increased bone resorption, while human osteoclasts from aged donors similarly showed prolonged persistence. Mechanistically, ATPase inhibitory factor 1 (ATPIF1) was required for this aging-associated metabolic state. Osteoclast-lineage deletion of Atpif1 reduced IDH3A expression, -ketoglutarate accumulation, glycolytic ATP production, and resorptive function ex vivo, while attenuating age-related cortical bone loss and porosity in vivo. Pharmacologic perturbation of IDH3-linked metabolism similarly suppressed glycolytic ATP production and osteoclast activity and increased cortical bone mass in aged mice. Together, these findings identify glycolysis-centered metabolic rewiring as a mechanism that sustains osteoclast survival and resorption during skeletal aging and implicate an ATPIF1-IDH3A metabolic axis as a potential therapeutic target for age-associated osteoporosis.
    DOI:  https://doi.org/10.21203/rs.3.rs-11273064/v1